Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease

Research output: Contribution to journalArticle

Abstract

Huntington's disease (HD) is a devastating neurodegenerative disorder which is inherited in an autosomal dominant manner. HD is caused by a trinucleotide CAG repeat expansion that encodes a polyglutamine stretch in the huntingtin (HTT) protein. Mutant HTT expression leads to a myriad of cellular dysfunctions culminating in neuronal loss and consequent motor, cognitive and psychiatric disturbances in HD patients. The length of the CAG repeat is inversely correlated with age of onset (AO) in HD patients, while environmental and genetic factors can further modulate this parameter. Here, we explored whether the recently described copy-number variation (CNV) of the gene SLC2A3-which encodes the neuronal glucose transporter GLUT3-could modulate AO in HD. Strikingly, we found that increased dosage of SLC2A3 delayed AO in an HD cohort of 987 individuals, and that this correlated with increased levels of GLUT3 in HD patient cells. To our knowledge this is the first time that CNV of a candidate gene has been found to modulate HD pathogenesis. Furthermore, we found that increasing dosage of Glut1-the Drosophila melanogaster homologue of this glucose transporter-ameliorated HD-relevant phenotypes in fruit flies, including neurodegeneration and life expectancy. As alterations in glucose metabolism have been implicated in HD pathogenesis, this study may have important therapeutic relevance for HD.

Original languageEnglish
Pages (from-to)3129-3137
Number of pages9
JournalHuman Molecular Genetics
Volume23
Issue number12
DOIs
Publication statusPublished - 15 Jun 2014

Fingerprint

Facilitative Glucose Transport Proteins
Huntington Disease
Age of Onset
Genes
Trinucleotide Repeat Expansion
Gene Dosage
Life Expectancy
Drosophila melanogaster
Diptera
Neurodegenerative Diseases
Psychiatry
Fruit
Phenotype
Glucose

Bibliographical note

© The Author 2014. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

  • Age of Onset
  • Animals
  • Cell Line
  • Cohort Studies
  • DNA Copy Number Variations
  • Disease Models, Animal
  • Drosophila Proteins/genetics
  • Drosophila melanogaster/metabolism
  • Female
  • Gene Dosage
  • Glucose Transporter Type 3/genetics
  • Humans
  • Huntington Disease/epidemiology
  • Male
  • Phylogeny
  • Up-Regulation

Cite this

@article{0fe4b9e074044a06bd25375ff30e6426,
title = "Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease",
abstract = "Huntington's disease (HD) is a devastating neurodegenerative disorder which is inherited in an autosomal dominant manner. HD is caused by a trinucleotide CAG repeat expansion that encodes a polyglutamine stretch in the huntingtin (HTT) protein. Mutant HTT expression leads to a myriad of cellular dysfunctions culminating in neuronal loss and consequent motor, cognitive and psychiatric disturbances in HD patients. The length of the CAG repeat is inversely correlated with age of onset (AO) in HD patients, while environmental and genetic factors can further modulate this parameter. Here, we explored whether the recently described copy-number variation (CNV) of the gene SLC2A3-which encodes the neuronal glucose transporter GLUT3-could modulate AO in HD. Strikingly, we found that increased dosage of SLC2A3 delayed AO in an HD cohort of 987 individuals, and that this correlated with increased levels of GLUT3 in HD patient cells. To our knowledge this is the first time that CNV of a candidate gene has been found to modulate HD pathogenesis. Furthermore, we found that increasing dosage of Glut1-the Drosophila melanogaster homologue of this glucose transporter-ameliorated HD-relevant phenotypes in fruit flies, including neurodegeneration and life expectancy. As alterations in glucose metabolism have been implicated in HD pathogenesis, this study may have important therapeutic relevance for HD.",
keywords = "Age of Onset, Animals, Cell Line, Cohort Studies, DNA Copy Number Variations, Disease Models, Animal, Drosophila Proteins/genetics, Drosophila melanogaster/metabolism, Female, Gene Dosage, Glucose Transporter Type 3/genetics, Humans, Huntington Disease/epidemiology, Male, Phylogeny, Up-Regulation",
author = "Angelica Vittori and Carlo Breda and Mariaelena Repici and Michael Orth and Roos, {Raymund A C} and Outeiro, {Tiago F} and Flaviano Giorgini and Hollox, {Edward J}",
note = "{\circledC} The Author 2014. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",
year = "2014",
month = "6",
day = "15",
doi = "10.1093/hmg/ddu022",
language = "English",
volume = "23",
pages = "3129--3137",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "12",

}

Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease. /.

In: Human Molecular Genetics, Vol. 23, No. 12, 15.06.2014, p. 3129-3137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease

AU - Vittori, Angelica

AU - Breda, Carlo

AU - Repici, Mariaelena

AU - Orth, Michael

AU - Roos, Raymund A C

AU - Outeiro, Tiago F

AU - Giorgini, Flaviano

AU - Hollox, Edward J

N1 - © The Author 2014. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2014/6/15

Y1 - 2014/6/15

N2 - Huntington's disease (HD) is a devastating neurodegenerative disorder which is inherited in an autosomal dominant manner. HD is caused by a trinucleotide CAG repeat expansion that encodes a polyglutamine stretch in the huntingtin (HTT) protein. Mutant HTT expression leads to a myriad of cellular dysfunctions culminating in neuronal loss and consequent motor, cognitive and psychiatric disturbances in HD patients. The length of the CAG repeat is inversely correlated with age of onset (AO) in HD patients, while environmental and genetic factors can further modulate this parameter. Here, we explored whether the recently described copy-number variation (CNV) of the gene SLC2A3-which encodes the neuronal glucose transporter GLUT3-could modulate AO in HD. Strikingly, we found that increased dosage of SLC2A3 delayed AO in an HD cohort of 987 individuals, and that this correlated with increased levels of GLUT3 in HD patient cells. To our knowledge this is the first time that CNV of a candidate gene has been found to modulate HD pathogenesis. Furthermore, we found that increasing dosage of Glut1-the Drosophila melanogaster homologue of this glucose transporter-ameliorated HD-relevant phenotypes in fruit flies, including neurodegeneration and life expectancy. As alterations in glucose metabolism have been implicated in HD pathogenesis, this study may have important therapeutic relevance for HD.

AB - Huntington's disease (HD) is a devastating neurodegenerative disorder which is inherited in an autosomal dominant manner. HD is caused by a trinucleotide CAG repeat expansion that encodes a polyglutamine stretch in the huntingtin (HTT) protein. Mutant HTT expression leads to a myriad of cellular dysfunctions culminating in neuronal loss and consequent motor, cognitive and psychiatric disturbances in HD patients. The length of the CAG repeat is inversely correlated with age of onset (AO) in HD patients, while environmental and genetic factors can further modulate this parameter. Here, we explored whether the recently described copy-number variation (CNV) of the gene SLC2A3-which encodes the neuronal glucose transporter GLUT3-could modulate AO in HD. Strikingly, we found that increased dosage of SLC2A3 delayed AO in an HD cohort of 987 individuals, and that this correlated with increased levels of GLUT3 in HD patient cells. To our knowledge this is the first time that CNV of a candidate gene has been found to modulate HD pathogenesis. Furthermore, we found that increasing dosage of Glut1-the Drosophila melanogaster homologue of this glucose transporter-ameliorated HD-relevant phenotypes in fruit flies, including neurodegeneration and life expectancy. As alterations in glucose metabolism have been implicated in HD pathogenesis, this study may have important therapeutic relevance for HD.

KW - Age of Onset

KW - Animals

KW - Cell Line

KW - Cohort Studies

KW - DNA Copy Number Variations

KW - Disease Models, Animal

KW - Drosophila Proteins/genetics

KW - Drosophila melanogaster/metabolism

KW - Female

KW - Gene Dosage

KW - Glucose Transporter Type 3/genetics

KW - Humans

KW - Huntington Disease/epidemiology

KW - Male

KW - Phylogeny

KW - Up-Regulation

UR - https://academic.oup.com/hmg/article/23/12/3129/696124

U2 - 10.1093/hmg/ddu022

DO - 10.1093/hmg/ddu022

M3 - Article

C2 - 24452335

VL - 23

SP - 3129

EP - 3137

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 12

ER -